Cargando…
Cardiovascular manifestation and treatment in COVID-19
The novel coronavirus disease 2019 (COVID-19), with first presentation of atypical pneumonia, has spread rapidly from Wuhan, China, on December 12, 2019 to over 200 countries, caused 2 310 572 infected individuals and 158 691 mortalities, updated on April 19, 2020. Many studies have published timely...
Autores principales: | Su, Yen-Bo, Kuo, Ming-Jen, Lin, Ting-Yu, Chien, Chian-Shiu, Yang, Yi-Ping, Chou, Shih-Jie, Leu, Hsin-Bang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493780/ https://www.ncbi.nlm.nih.gov/pubmed/32433342 http://dx.doi.org/10.1097/JCMA.0000000000000352 |
Ejemplares similares
-
Reversal of the Inflammatory Responses in Fabry Patient iPSC-Derived Cardiovascular Endothelial Cells by CRISPR/Cas9-Corrected Mutation
por: Song, Hui-Yung, et al.
Publicado: (2021) -
Generation of GLA-Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy
por: Song, Hui-Yung, et al.
Publicado: (2019) -
Dual DNA Transfection Using 1,6-Hexanedithiol-Conjugated Maleimide-Functionalized PU-PEI(600) For Gene Correction in a Patient iPSC-Derived Fabry Cardiomyopathy Model
por: Chien, Chian-Shiu, et al.
Publicado: (2021) -
Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1
por: Yarmishyn, Aliaksandr A., et al.
Publicado: (2020) -
Using CRISPR/Cas9-Mediated GLA Gene Knockout as an In Vitro Drug Screening Model for Fabry Disease
por: Song, Hui-Yung, et al.
Publicado: (2016)